Disease Overview：Congenital Heart Defects
Congenital heart defects (CHDs) are structural abnormalities of the heart or great vessels present at birth, arising from disrupted embryonic development. Common types include ventricular septal defect (VSD), atrial septal defect (ASD), tetralogy of Fallot (TOF), patent ductus arteriosus (PDA), and complex lesions such as transposition of the great arteries (TGA). Severity ranges from asymptomatic minor shunts to life-threatening cyanotic conditions requiring urgent intervention. Diagnosis relies on echocardiography—particularly fetal and neonatal transthoracic echocardiography—as well as cardiac MRI and catheterization when indicated. Surgical correction may involve patch closure, valve repair/replacement, arterial switch procedures, or hybrid interventions combining surgical and interventional techniques. Long-term outcomes depend on lesion complexity, timing of intervention, and multidisciplinary follow-up involving pediatric cardiologists, cardiothoracic surgeons, and electrophysiologists.
China offers compelling advantages for CHD management: its top-tier cardiovascular centers—many affiliated with universities like Peking Union Medical College Hospital and Shanghai Children’s Medical Center—boast internationally trained surgeons with extensive experience in both conventional and minimally invasive repairs. Advanced intraoperative imaging, 3D-printed anatomical models for pre-surgical planning, and robotic-assisted techniques enhance precision. Over 95% survival rates for common defects and robust registries documenting >10,000 annual pediatric cardiac surgeries reflect consistent clinical excellence. Costs remain significantly lower than in the US or Western Europe—often 40–60% less—without compromising safety or outcomes. As a dedicated medical tourism agency, we facilitate seamless international care: verifying hospital credentials, coordinating appointments with certified specialists, providing itemized, transparent pricing in advance, arranging visas and local logistics, and offering bilingual clinical support throughout diagnosis, treatment, and recovery.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Congenital Heart Defects (Cardiothoracic Surgery)
Non-Surgical / Conservative Management
*Indicated for mild defects (e.g., small ASD/VSD with no hemodynamic impact), stable cyanotic lesions awaiting surgery, or palliative support in high-risk infants.*
- •Medical Therapy
- Beta-blockers (propranolol): ¥60–¥180/month ($8–$25) - Prostaglandin E1 infusion (for ductal-dependent lesions): ¥3,200–¥5,800/course ($450–$810)
- •Monitoring & Diagnostic Fees
- Holter monitoring (24-hr): ¥320–¥450 ($45–$63) - BNP/NT-proBNP assay: ¥180–¥260 ($25–$36) - Serial oxygen saturation & growth tracking (clinic visit): ¥120–¥200/visit ($17–$28)
Surgical & Interventional Procedures
*All procedures performed by Cardiothoracic Surgery departments in Grade 3A hospitals.*
- •Catheter-Based Interventions
- Balloon valvuloplasty (pulmonary/aortic): ¥22,000–¥35,000 ($3,070–$4,880) - Pre-op workup (CT angiography + coagulation panel + echo): ¥2,900–¥4,100 ($405–$570)
- •Open-Heart Surgery
- Complex repair (e.g., TOF repair, arterial switch): ¥112,000–¥168,000 ($15,630–$23,440) - Pre-op workup (MRI + cardiac catheterization + genetic testing if indicated): ¥6,400–¥9,800 ($890–$1,370)
Special/Complex Condition Management
- •Single-Ventricle Pathway (e.g., HLHS)
- Bidirectional Glenn (Stage II): ¥88,000–¥115,000 ($12,280–$16,050) - Fontan completion (Stage III): ¥102,000–¥138,000 ($14,230–$19,250)
- •Transplantation (Rare, end-stage failure)
Quick Selection Guide
- •Neonates (<1 mo) with ductal-dependent circulation: Immediate PGE1 infusion + urgent catheter-based duct stenting or Norwood — *prioritize centers with neonatal ECMO capability*.
- •Infants (1–12 mo) with moderate shunt lesions: Early surgical repair (VSD/ASD closure) — optimal balance of risk, cost, and long-term outcome.
- •Children (>2 yr) with simple defects: Catheter closure preferred — lower cost, faster recovery, avoids sternotomy.
- •Adults with unrepaired defects or Eisenmenger syndrome: Conservative management only — surgery contraindicated; focus on pulmonary vasodilators and O₂ therapy.
- •Low-budget families: Start with echocardiogram + medical stabilization; pursue provincial health insurance reimbursement (covers 65–85% of listed procedure costs in 3A hospitals).
- •High-comorbidity patients (renal/hepatic dysfunction): Individualized catheter-based approach or staged palliation — avoid prolonged CPB time.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Congenital Heart Defects Medical Vacation Packages
Curated transparent all-inclusive packages combining Congenital Heart Defects treatment with China top medical destinations:
